Advance in the study on the relationship among salt, intestinal microbiota and its metabolites, and blood pressure
Author:
Affiliation:

1.Qinghai University,Xining, Qinghai 810000, China ;2.Department of Cardiology, Affiliated Hospital of Qinghai University, Xining, Qinghai 810000, China)

Clc Number:

R544.1

  • Article
  • | |
  • Metrics
  • |
  • Reference [49]
  • |
  • Related
  • | | |
  • Comments
    Abstract:

    With the deepening understanding of hypertension, more and more evidence suggests that the blood pressure levels of hypertensive patients are closely related to sodium salts. The gut microbiome is made up of bacteria, archaea, fungi, protozoa and viruses, also known as the gut microbiome, intestinal flora and its metabolites, as a hot research direction in hypertension, play an important role in the relationship between sodium and blood pressure. Excessive sodium salt can change the type and proportion of intestinal microbiota, affect the level of inflammation and metabolism of the body and accelerate the occurrence and development of hypertension. Sodium control is a low-cost and effective way to control blood pressure. This article reviews the complex relationship between sodium salts, gut microbiota, and hypertension, hoping to provide theoretical support for the prevention, treatment, and control of hypertension.

    Reference
    [1] AL-MAKKI A, DIPETTE D, WHELTON P K, et al.Hypertension pharmacological treatment in adults:A World Health Organization Guideline Executive Summary.Hypertension, 2,9:293-301.
    [2] NCD Risk Factor Collaboration (NCD-RisC).Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019:a pooled analysis of 1 201 population-representative studies with 104 million participants.Lancet, 1,8:957-980.
    [3] AIRD W C.Discovery of the cardiovascular system:from Galen to William Harvey.J Thromb Haemost, 2011.DOI:10.1111/j.1538-7836.2011.04312.x.
    [4] TREMAROLI V, BCKHED F.Functional interactions between the gut microbiota and host metabolism.Nature, 2,9:242-249.
    [5] MAALIKI D, ITANI M M, ITANI H A.Pathophysiology and genetics of salt-sensitive hypertension.Front Physiol, 2,3:1001434.
    [6] COFFMAN T M.Under pressure:the search for the essential mechanisms of hypertension.Nat Med, 1,7:1402-1409.
    [7] WILCK N, MATUS M G, KEARNEY S M, et al.Salt-responsive gut commensal modulates TH17 axis and disease.Nature, 7,1(7682):585-589.
    [8] MINEGISHI S, LUFT F C, TITZE J, et al.Sodium handling and interaction in numerous organs.Am J Hypertens, 0,3:687-694.
    [9] LITTLE R, MURALI S K, POULSEN S B, et al.Dissociation of sodium-chloride cotransporter expression and blood pressure during chronic high dietary potassium supplementation.JCI Insight, 3,8:8(5):e156437.
    [10] ELIJOVICH F, WEINBERGER M H, ANDERSON C A, et al.Salt sensitivity of blood pressure:a scientific statement from the American Heart Association.Hypertension, 6,8:e7-e46.
    [11] GBD 2017 Diet Collaborators.Health effects of dietary risks in 195 countries, 1990-2017:a systematic analysis for the Global Burden of Disease Study 2017.Lancet, 9,3:1958-1972.
    [12] CAMPBELL N R C, HE F J, TAN M, et al.The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intake.J Clin Hypertens (Greenwich), 9,1:700-709.
    [13] HE F J, LI J, MACGREGOR G A.Effect of longer term modest salt reduction on blood pressure:cochrane systematic review and Meta-analysis of randomised trials.BMJ, 3,6:f1325.
    [14] XU A Q, MA J X, GUO X L, et al.Association of a Province-Wide Intervention With Salt Intake and Hypertension in Shandong Province, China, 2011-2016.JAMA Intern Med, 0,0:877-886.
    [15] WANG J G, ZHANG W, LI Y, et al.Hypertension in China:epidemiology and treatment initiatives.Nat Rev Cardiol, 3,0(8):531-545.
    [16] 孙宁玲, 姜一农, 王鸿懿, 等.我国高血压患者的钠盐摄入现状.中华高血压杂志, 0,8(11):1025-1030.SUN N L, JIANG Y N, WANG H Y, et al.Sodium intake status of patients with high blood pressure in China.Chin J Hypertens, 0,8(11):1025-1030.
    [17] PESTANA-OLIVEIRA N, NAHEY DB, HARTSON R, et al.DOCA-salt hypertension and the role of the OVLT-sympathetic-gut microbiome axis.Clin Exp Pharmacol Physiol, 1,8:490-497.
    [18] BIER A, BRAUN T, KHASBAB R, et al.A high salt diet modulates the gut microbiota and short chain fatty acids production in a salt-sensitive hypertension rat model.Nutrients, 8,0 (9):1154.
    [19] FERGUSON J F, ADEN L A, BARBARO N R, et al.High dietary salt-induced dendritic cell activation underlies microbial dysbiosis-associated hypertension.JCI Insight, 9,5 (13):e126241.
    [20] YAN X F, JIN J J, SU X H, et al.Intestinal flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension.Circ Res, 0,6:839-853.
    [21] LI J, GAO Q N, Ma Y Y Z, et al.Causality of opportunistic pathogen Klebsiella pneumoniae to hypertension development.Hypertension, 2,9:2743-2754.
    [22] QIN Y L, ZHAO J, WANG Y W, et al.Specific alterations of gut microbiota in Chinese patients with hypertension:a systematic review and Meta-analysis.Kidney Blood Press Res, 2,7:433-447.
    [23] MAGALHES N S, SAVINO W, SILVA P M R, et al.Gut microbiota dysbiosis is a crucial player for the poor outcomes for COVID-19 in elderly, diabetic and hypertensive patients.Front Med (Lausanne), 1,8:644751.
    [24] COOK K L, CHAPPELL M C.Gut dysbiosis and hypertension:is it cause or effect?.J Hypertens, 1,9:1768-1770.
    [25] NAQVI S, ASAR T O, KUMAR V, et al.A cross-talk between gut microbiome, salt and hypertension.Biomed Pharmacother, 1,4:111156.
    [26] GAUNDAL L, MYHRSTAD M C W, RUD I, et al.Gut microbiota is associated with dietary intake and metabolic markers in healthy individuals.Food Nutr Res, 2,3:66.
    [27] MIRANDA P M, DE PALMA G, SERKIS V, et al.High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production.Microbiome, 8,6:57.
    [28] CANALE M P, NOCE A, DI LAURO M, et al.Gut dysbiosis and western diet in the pathogenesis of essential arterial hypertension:a narrative review.Nutrients, 1,3(4):1162.
    [29] ZHENG T, WU Y, PENG M J, et al.Hypertension of liver-yang hyperactivity syndrome induced by a high salt diet by altering components of the gut microbiota associated with the glutamate/GABA-glutamine cycle.Front Nutr, 2,9:964273.
    [30] 陈杰, 陈宣颖, 孙立勤, 等.宁波地区盐敏感性高血压患者基于16 s rRNA检测肠道菌群的特征分析.现代实用医学, 1,3(11):1458-1459.CHEN J, CHEN X Y, SUN L Q, et al.Analysis of intestinal flora in patients with salt-sensitive hypertension based on 16 s rRNA.Mod Pract Med, 1,3(11):1458-1459.
    [31] 黄庆发.高盐饮食改变肠道菌群结构导致高血压的发生.广州:南方医科大学, 2020.DOI:10.27003/d.cnki.gojyu.2020.000362.HUANG Q F.High salt diet changes of intestinal flora structure leads to the occurrence of hypertension.Guangzhou:Southern Medical University, 2020.DOI:10.27003/d.cnki.gojyu.2020.000362.
    [32] RUAN Z L, LI J X, LIU F C, et al.Study design, general characteristics of participants, and preliminary findings from the metabolome, microbiome, and dietary salt intervention study (MetaSalt).Chronic Dis Transl Med, 1,7:227-234.
    [33] CHEN L, HE F J, DONG Y B, et al.Modest sodium reduction increases circulating short-chain fatty acids in untreated hypertensives:a randomized, double-blind, placebo-controlled trial.Hypertension, 0,6:73-79.
    [34] LU W W, WANG Y S, FANG Z F, et al.Bifidobacterium longum CCFM752 prevented hypertension and aortic lesion, improved antioxidative ability, and regulated the gut microbiome in spontaneously hypertensive rats.Food Funct, 2,3:6373-6386.
    [35] LAKSHMANAN A P, SHATAT I F, ZAIDAN S, et al.Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus.Biomed Pharmacother, 1,0:111736.
    [36] BOMFIM G F, DOS S R A, OLIVEIRA M A, et al.Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats.Clin Sci (Lond), 2,2:535-543.
    [37] ROBACZEWSKA J, KEDZIORA-KORNATOWSKA K, KOZAKIEWICZ M, et al.Role of glutathione metabolism and glutathione-related antioxidant defense systems in hypertension.J Physiol Pharmacol, 6,7:331-337.
    [38] ELIJOVICH F, LAFFER C L, SAHINOZ M, et al.The gut microbiome, inflammation, and salt-sensitive hypertension.Curr Hypertens Rep, 0,2:79.
    [39] WENZEL U O, BODE M, KURTS C, et al.Salt, inflammation, IL-17 and hypertension.Br J Pharmacol, 9,6:1853-1863.
    [40] BASILE D P, ABAIS-BATTAD J M, MATTSON D L.Contribution of Th17 cells to tissue injury in hypertension.Curr Opin Nephrol Hypertens, 1,0:151-158.
    [41] MIZOGUCHI T, KASAHARA K, YAMASHITA T, et al.Oral administration of the lactic acid bacterium Pediococcus acidilactici attenuates atherosclerosis in mice by inducing tolerogenic dendritic cells.Heart Vessels, 7,2:768-776.
    [42] RAZAVI A C, POTTS K S, KELLY T N, et al.Sex, gut microbiome, and cardiovascular disease risk.Biol Sex Differ, 9,0:29.
    [43] 王欢, 苏晓敏, 杨雪峰, 等.髓系细胞血管紧张素1型受体在盐敏感性高血压小鼠血管胰岛素抵抗和血管损伤中的作用.中国动脉硬化杂志, 3,1(1):41-48.WANG H, SU X M, YANG X F, et al.Effect of myeloid angiotensin type 1 receptor on vascular insulin resistance and vascular injury in salt-sensitive hypertensive mice.Chin J Arterioscler, 3,1(1):41-48.
    [44] WILCK N, BALOGH A, MARK L, et al.The role of sodium in modulating immune cell function.Nat Rev Nephrol, 9,5:546-558.
    [45] XU D, HU J, WANG S, et al.Trends in the prevalence of hypertensive heart disease in China from 1990 to 2019:a joinpoint and age-period-cohort analysis.Front Public Health, 2,0:833345.
    [46] 健康中国行动推进委员会.健康中国行动(2019─2030年):总体要求、重大行动及主要指标.中国循环杂志, 9,4(9):846-858.Health China Action Promotion Committee.Healthy China Action (2019-2030):overall requirements, major actions and key indicators .Chin J Circ, 9,4(9):846-858.
    [47] 国务院办公厅.国务院办公厅关于印发中国防治慢性病中长期规划(2017—2025年)的通知[EB/OL].[2017-02-14].http://www.gov.cn/zhengce/content/2017-02/14/content_5167886.htm.General Office of the State Council.Notice of the General Office of the State Council on Issuing the Medium and Long Term Plan for the Prevention and Control of Chronic Diseases in China (2017-2025) [EB/OL].[2017-02-14].http://www.gov.cn/zhengce/content/2017-02/14/content_5167886.htm.
    [48] 国家卫生健康委办公厅.国家卫生健康委办公厅关于印发成人高脂血症食养指南(2023年版)等4项食养指南的通知[EB/OL].[2023-01-18].http://www.nhc.gov.cn/sps/s7887k/202301/0e55a 01df50c47d9a4a43db026e3afc3.shtml.General Office of the National Health Commission.Notice of the General Office of the National Health Commission on Issuing Four Dietary Guidelines for Adult Hyperlipidemia (2023 Edition)[EB/OL].[2023-01-18].http://www.nhc.gov.cn/sps/s7887k/202301/0e55a01df 50c47d9a4a43db026e3afc3.shtml.
    [49] PAGONAS N, SASKO B, RITTER O.Managing hypertension in the future:a multifactorial approach.Eur J Prev Cardiol, 3,0:46-47.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

LI Heng, REN Ming. Advance in the study on the relationship among salt, intestinal microbiota and its metabolites, and blood pressure[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(11):1007-1012.

Copy
Share
Article Metrics
  • Abstract:317
  • PDF: 825
  • HTML: 0
  • Cited by: 0
History
  • Received:March 09,2023
  • Revised:April 15,2023
  • Online: December 05,2023
Article QR Code